{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:29:47Z","timestamp":1790702987749,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Henan Province Medical Science and Technology Tackling Provincial Ministry Youth Project","award":["No SBGJ2021030564"],"award-info":[{"award-number":["No SBGJ2021030564"]}]},{"name":"The present study was supported by Henan Medical Science and Technology Research Project of 2018","award":["No SBGJ2018002"],"award-info":[{"award-number":["No SBGJ2018002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pancreatic adenocarcinoma (PAAD) is a frequent type of cancer in adults worldwide, and the search for better biomarkers is one of the current challenges. Although RAB7A is associated with tumour progression in multiple tumour types, there are only a few reports in PAAD. Therefore, in this paper, RNA sequencing data were obtained from TCGA(The Cancer Genome Atlas) and GTEx to analyse RAB7A expression and differentially expressed genes (DEGs) in PAAD. The functional enrichment of RAB7A-associated DEGs was analysed by protein\u2012protein interaction (PPI) networks, immune cell infiltration analysis and GO\/KEGG analyses. Additionally, Kaplan\u2012Meier and Cox regression analyses were used to determine the clinical significance of RAB7A in PAAD. High RAB7A expression was associated with poor prognosis in 182 PAAD specimens, including subgroups of patients aged\u2009\u2264\u200965\u00a0years, with male sex, not receiving radiotherapy, and with a history of previous alcohol consumption (P\u2009&lt;\u20090.05). Cox regression analysis showed that elevated RAB7A was an independent prognostic factor, and the prognostic nomogram model included radiotherapy status, presence of postoperative tumour residual and histologic grade. Overall, RAB7A overexpression may serve as a biomarker for poor outcome in pancreatic cancer. The DEGs and pathways revealed in this work provide a tentative molecular mechanism for the pathogenesis and progression of PAAD.<\/jats:p>","DOI":"10.1038\/s41598-022-22355-1","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T16:02:52Z","timestamp":1666195372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["High RAS-related protein Rab-7a (RAB7A) expression is a poor prognostic factor in pancreatic adenocarcinoma"],"prefix":"10.1038","volume":"12","author":[{"given":"Qi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-zhi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,19]]},"reference":[{"key":"22355_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"22355_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel, R. L. et al. Cancer Statistics, 2021. CA Cancer J. Clin. 71, 7\u201333 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"22355_CR3","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.pan.2020.02.011","volume":"20","author":"X Chen","year":"2020","unstructured":"Chen, X. et al. Global, regional and national burden of pancreatic cancer, 1990 to 2017: Results from the Global Burden of Disease Study 2017. Pancreatology 20, 462\u2013469 (2020).","journal-title":"Pancreatology"},{"key":"22355_CR4","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3390\/diagnostics11030562","volume":"11","author":"J Ushio","year":"2021","unstructured":"Ushio, J. et al. Pancreatic ductal adenocarcinoma: Epidemiology and risk factors. Diagnostics 11, 562 (2021).","journal-title":"Diagnostics"},{"key":"22355_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.surg.2020.12.003","volume":"170","author":"JJ Hue","year":"2021","unstructured":"Hue, J. J. et al. Facility volume-survival relationship in patients with early-stage pancreatic adenocarcinoma treated with neoadjuvant chemotherapy followed by pancreatoduodenectomy. Surgery 170, 207\u2013214 (2021).","journal-title":"Surgery"},{"key":"22355_CR6","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S1097-2765(03)00401-5","volume":"12","author":"MD Snider","year":"2003","unstructured":"Snider, M. D. A role for rab7 GTPase in growth factor-regulated cell nutrition and apoptosis. Mol. Cell 12, 796\u2013797 (2003).","journal-title":"Mol. Cell"},{"key":"22355_CR7","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1242\/jcs.051474","volume":"123","author":"C Progida","year":"2010","unstructured":"Progida, C. et al. Rab7b controls trafficking from endosomes to the TGN. J. Cell Sci. 123, 1480\u20131491 (2010).","journal-title":"J. Cell Sci."},{"key":"22355_CR8","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1002\/jnr.24034","volume":"95","author":"H Wen","year":"2017","unstructured":"Wen, H. et al. Rab7 may be a novel therapeutic target for neurologic diseases as a key regulator in autophagy. J. Neurosci. Res. 95, 1993\u20132004 (2017).","journal-title":"J. Neurosci. Res."},{"key":"22355_CR9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.bbamcr.2012.11.018","volume":"1833","author":"JM Hyttinen","year":"2013","unstructured":"Hyttinen, J. M. et al. Maturation of autophagosomes and endosomes: A key role for Rab7. Biochim. Biophys. Acta 1833, 503\u2013510 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"22355_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/cells5030034","volume":"5","author":"F Guerra","year":"2016","unstructured":"Guerra, F. et al. Multiple roles of the small GTPase Rab7. Cells 5, 34 (2016).","journal-title":"Cells"},{"key":"22355_CR11","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nbt.3772","volume":"35","author":"J Vivian","year":"2017","unstructured":"Vivian, J. et al. Toil enables reproducible, open source, big biomedical data analyses. Nat. Biotechnol. 35, 314 (2017).","journal-title":"Nat. Biotechnol."},{"key":"22355_CR12","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I. et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"22355_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. et al. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"22355_CR14","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"22355_CR15","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa, M. et al. KEGG: Integrating viruses and cellular organisms. Nucleic Acids Res. 49, D545\u2013D551 (2021).","journal-title":"Nucleic Acids Res."},{"key":"22355_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G. et al. clusterProfiler: An R package for comparing biological themes among gene clusters. Omics 16, 284\u2013287 (2012).","journal-title":"Omics"},{"key":"22355_CR17","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"22355_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S. et al. GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"key":"22355_CR19","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea, G. et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39, 782\u2013795 (2013).","journal-title":"Immunity"},{"key":"22355_CR20","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk, D. et al. STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607\u2013D613 (2019).","journal-title":"Nucleic Acids Res."},{"key":"22355_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.12688\/f1000research.4492.2","volume":"3","author":"B Demchak","year":"2014","unstructured":"Demchak, B. et al. Cytoscape: The network visualization tool for genomespace workflows. F1000Res. 3, 151 (2014).","journal-title":"F1000Res."},{"key":"22355_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1532-429X-14-83","volume":"14","author":"WP Bandettini","year":"2012","unstructured":"Bandettini, W. P. et al. Multicontrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: A clinical validation study. J. Cardiovasc. Magn. Reson. 14, 83 (2012).","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"22355_CR23","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 173, 400-416.e411 (2018).","journal-title":"Cell"},{"key":"22355_CR24","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3390\/cancers11081096","volume":"11","author":"F Guerra","year":"2019","unstructured":"Guerra, F. et al. Role of the RAB7 protein in tumor progression and cisplatin chemoresistance. Cancers 11, 1096 (2019).","journal-title":"Cancers"},{"key":"22355_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3233\/CBM-170030","volume":"20","author":"N Suwandittakul","year":"2017","unstructured":"Suwandittakul, N. et al. Disruption of endocytic trafficking protein Rab7 impairs invasiveness of cholangiocarcinoma cells. Cancer Biomark. 20, 255\u2013266 (2017).","journal-title":"Cancer Biomark."},{"key":"22355_CR26","doi-asserted-by":"publisher","first-page":"8277","DOI":"10.1073\/pnas.122187699","volume":"99","author":"K Croizet-Berger","year":"2002","unstructured":"Croizet-Berger, K. et al. The endocytic catalysts, Rab5a and Rab7, are tandem regulators of thyroid hormone production. Proc. Natl. Acad. Sci. U. S. A. 99, 8277\u20138282 (2002).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"22355_CR27","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1158\/1078-0432.CCR-06-1059","volume":"12","author":"B Davidson","year":"2006","unstructured":"Davidson, B. et al. Gene expression signatures differentiate ovarian\/peritoneal serous carcinoma from diffuse malignant peritoneal mesothelioma. Clin. Cancer Res. 12, 5944\u20135950 (2006).","journal-title":"Clin. Cancer Res."},{"key":"22355_CR28","doi-asserted-by":"publisher","first-page":"460","DOI":"10.2174\/1568009611313040008","volume":"13","author":"A Dicitore","year":"2013","unstructured":"Dicitore, A. et al. Combined treatment with PPAR-\u03b3 agonists in pancreatic cancer: A glimmer of hope for cancer therapy?. Curr. Cancer Drug Targets 13, 460\u2013471 (2013).","journal-title":"Curr. Cancer Drug Targets"},{"key":"22355_CR29","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ejmech.2019.01.067","volume":"166","author":"AZ Mirza","year":"2019","unstructured":"Mirza, A. Z. et al. Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications. Eur. J. Med. Chem. 166, 502\u2013513 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"22355_CR30","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ccell.2020.03.013","volume":"37","author":"M Drosten","year":"2020","unstructured":"Drosten, M. et al. Targeting the MAPK pathway in KRAS-driven Tumors. Cancer Cell 37, 543\u2013550 (2020).","journal-title":"Cancer Cell"},{"key":"22355_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/978-1-60761-451-7_11","volume":"59","author":"L Simson","year":"2010","unstructured":"Simson, L. et al. The role of Th2-mediated anti-tumor immunity in tumor surveillance and clearance. Cancer IgE 59, 255\u2013275 (2010).","journal-title":"Cancer IgE"},{"key":"22355_CR32","doi-asserted-by":"publisher","first-page":"632581","DOI":"10.3389\/fimmu.2021.632581","volume":"12","author":"S Schreiber","year":"2021","unstructured":"Schreiber, S. et al. Metabolic interdependency of Th2 cell-mediated type 2 immunity and the tumor microenvironment. Front. Immunol. 12, 632581 (2021).","journal-title":"Front. Immunol."},{"key":"22355_CR33","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.4049\/jimmunol.145.9.3136","volume":"145","author":"M Bosco","year":"1990","unstructured":"Bosco, M. et al. Low doses of IL-4 injected perilymphatically in tumor-bearing mice inhibit the growth of poorly and apparently nonimmunogenic tumors and induce a tumor-specific immune memory. J. Immunol. 145, 3136\u20133143 (1990).","journal-title":"J. Immunol."},{"key":"22355_CR34","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.4049\/jimmunol.153.12.5659","volume":"153","author":"F Pericle","year":"1994","unstructured":"Pericle, F. et al. An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. J. Immunol. 153, 5659\u20135673 (1994).","journal-title":"J. Immunol."},{"key":"22355_CR35","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1126\/science.1636093","volume":"257","author":"RI Tepper","year":"1992","unstructured":"Tepper, R. I. et al. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 257, 548\u2013551 (1992).","journal-title":"Science"},{"key":"22355_CR36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/CJI.0000000000000231","volume":"41","author":"M Dai","year":"2018","unstructured":"Dai, M. et al. Tumor regression and cure depends on sustained Th1 responses. J. Immunother. 41, 369\u2013378 (2018).","journal-title":"J. Immunother."},{"key":"22355_CR37","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ygyno.2012.07.098","volume":"127","author":"Q Feng","year":"2012","unstructured":"Feng, Q. et al. Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma. Gynecol. Oncol. 127, 412\u2013419 (2012).","journal-title":"Gynecol. Oncol."},{"key":"22355_CR38","first-page":"567","volume":"53","author":"J Chen","year":"2018","unstructured":"Chen, J. et al. E2F1\/SP3\/STAT6 axis is required for IL-4-induced epithelial-mesenchymal transition of colorectal cancer cells. Int. J. Oncol. 53, 567\u2013578 (2018).","journal-title":"Int. J. Oncol."},{"key":"22355_CR39","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1158\/0008-5472.CAN-14-2379","volume":"75","author":"R Zaynagetdinov","year":"2015","unstructured":"Zaynagetdinov, R. et al. Interleukin-5 facilitates lung metastasis by modulating the immune microenvironment. Cancer Res. 75, 1624\u20131634 (2015).","journal-title":"Cancer Res."},{"key":"22355_CR40","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.1158\/0008-5472.CAN-14-3590","volume":"75","author":"Q Zhang","year":"2015","unstructured":"Zhang, Q. et al. CCL5-mediated Th2 immune polarization promotes metastasis in luminal breast cancer. Cancer Res. 75, 4312\u20134321 (2015).","journal-title":"Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22355-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22355-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22355-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T23:55:34Z","timestamp":1678319734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22355-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,19]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["22355"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-22355-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,19]]},"assertion":[{"value":"14 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17492"}}